Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome.
Kolevzon A, Levy T, Barkley S, Bedrosian-Sermone S, Davis M, Foss-Feig J, Halpern D, Keller K, Kostic A, Layton C, Lee R, Lerman B, Might M, Sandin S, Siper PM, Sloofman LG, Walker H, Zweifach J, Buxbaum JD. Kolevzon A, et al. Among authors: halpern d. HGG Adv. 2022 Aug 27;3(4):100138. doi: 10.1016/j.xhgg.2022.100138. eCollection 2022 Oct 13. HGG Adv. 2022. PMID: 36119806 Free PMC article.
Visual Evoked Potential Abnormalities in Phelan-McDermid Syndrome.
Siper PM, Rowe MA, Guillory SB, Rouhandeh AA, George-Jones JL, Tavassoli T, Lurie S, Zweifach J, Weissman J, Foss-Feig J, Halpern D, Trelles MP, Mulhern MS, Brittenham C, Gordon J, Zemon V, Buxbaum JD, Kolevzon A. Siper PM, et al. Among authors: halpern d. J Am Acad Child Adolesc Psychiatry. 2022 Apr;61(4):565-574.e1. doi: 10.1016/j.jaac.2021.07.006. Epub 2021 Jul 22. J Am Acad Child Adolesc Psychiatry. 2022. PMID: 34303785 Free PMC article.
Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium.
Levy T, Foss-Feig JH, Betancur C, Siper PM, Trelles-Thorne MDP, Halpern D, Frank Y, Lozano R, Layton C, Britvan B, Bernstein JA, Buxbaum JD, Berry-Kravis E, Powell CM, Srivastava S, Sahin M, Soorya L, Thurm A, Kolevzon A; Developmental Synaptopathies Consortium. Levy T, et al. Among authors: halpern d. Hum Mol Genet. 2022 Feb 21;31(4):625-637. doi: 10.1093/hmg/ddab280. Hum Mol Genet. 2022. PMID: 34559195 Free PMC article.
A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome.
Fastman J, Foss-Feig J, Frank Y, Halpern D, Harony-Nicolas H, Layton C, Sandin S, Siper P, Tang L, Trelles P, Zweifach J, Buxbaum JD, Kolevzon A. Fastman J, et al. Among authors: halpern d. Mol Autism. 2021 Sep 30;12(1):62. doi: 10.1186/s13229-021-00459-1. Mol Autism. 2021. PMID: 34593045 Free PMC article. Clinical Trial.
Social visual attentional engagement and memory in Phelan-McDermid syndrome and autism spectrum disorder: a pilot eye tracking study.
Guillory SB, Baskett VZ, Grosman HE, McLaughlin CS, Isenstein EL, Wilkinson E, Weissman J, Britvan B, Trelles MP, Halpern DB, Buxbaum JD, Siper PM, Wang AT, Kolevzon A, Foss-Feig JH. Guillory SB, et al. Among authors: halpern db. J Neurodev Disord. 2021 Dec 4;13(1):58. doi: 10.1186/s11689-021-09400-2. J Neurodev Disord. 2021. PMID: 34863106 Free PMC article.
Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome.
Kolevzon A, Breen MS, Siper PM, Halpern D, Frank Y, Rieger H, Weismann J, Trelles MP, Lerman B, Rapaport R, Buxbaum JD. Kolevzon A, et al. Among authors: halpern d. Mol Autism. 2022 Apr 8;13(1):17. doi: 10.1186/s13229-022-00493-7. Mol Autism. 2022. PMID: 35395866 Free PMC article. Clinical Trial.
293 results